Comparative efficacy of two once daily methylphenidate formulations (Ritalin® LA™ and Concerta®) and placebo in children with attention deficit hyperactivity disorder across the school day

Pediatric Drugs

Volumn 5, Issue 8, 2003, Pages 545-555

  Lopez, Frank ^a   Silva, Raul ^b   Pestreich, Linda ^c   Muniz, Rafael ^c  

^a Children's Developmental Center   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ABDOMINAL PAIN; AREA UNDER THE CURVE; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG CAPSULE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DYSPNEA; FEMALE; HUMAN; MALE; MENTAL PERFORMANCE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL; SINGLE BLIND PROCEDURE; TABLET;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CROSS-OVER STUDIES; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHYLPHENIDATE; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 0042825435     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200305080-00005     Document Type: Article

References (18)

1. Barkley RA. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guilford Press, 1990
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association, 1994
3. Bradley C. The behavior of children receiving benzedrine. Am J Psychiatry 1937;94: 577-85
4. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996; 98: 1084-8
5. Swanson J, Gupta S, Guinta D, et al. Acute tolerance of methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther 1999; 66: 295-305
6. Barkley RA, DuPaul GJ, Connor DF, Stimulants. In: Werry JS, Aman MG, editors. Practitioner's guide to psychoactive drugs for children and adolescents. New York: Plenum Medical Book Company, 1999: 213-41
7. Vitiello B. Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder. CMAJ 2001; 165 (11): 1505-6
8. Concerta® package insert. Mountain View (CA): Alza Corporation. 2001
9. Wolraich ML, Greenhill LL, Pelham W, et al. Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics 2001; 108 (4): 883-92
10. Ritalin® package insert. East Hanover (NJ): Novartis Pharmaceuticals Corporation, 2002
11. Markowitz JS, Straughn AB, Patrick KS, et al. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Clin Pharmacokinet 2003; 42 (4): 393-401
12. C-DISC: diagnostic interview schedule for children - generic DISC-IV. Version 7/01. Manhattan (NY): Columbia University, 1997
13. Swanson JM, Wigal S, Greenhill LL, et al. Objective and subjective measures of pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled analog classroom setting. Psychopharmacol Bull 1998; 34 (1): 55-60
14. Wigal S, Gupta S, Guinta D, et al. Reliability and validity of the SKAMP Rating Scale in a laboratory school setting. Psychopharmacol Bull 1998; 34 (1): 47-53
15. Novartis Pharmaceuticals Corporation. Data on file
16. Spilker B. Guide to clinical trials. Philadelphia (PA): Lippincott Williams and Wilkins, 2000: 29-35
17. Swanson JM, Gupta S, Williams L, et al. Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground. J Am Acad Child Adolesc Psychiatry 2002; 41 (11): 1306-14
18. Mitsis EM, McKay KE, Schulz KP, et al. Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry 2000; 39 (3): 308-13